Kura Oncology Stock Forecast - Polynomial Regression
| KURA Stock | USD 11.17 0.42 3.91% |
The Polynomial Regression forecasted value of Kura Oncology on the next trading day is expected to be 10.26 with a mean absolute deviation of 0.91 and the sum of the absolute errors of 55.53. Kura Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Kura Oncology stock prices and determine the direction of Kura Oncology's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Kura Oncology's historical fundamentals, such as revenue growth or operating cash flow patterns.
Kura |
Kura Oncology Polynomial Regression Price Forecast For the 29th of November
Given 90 days horizon, the Polynomial Regression forecasted value of Kura Oncology on the next trading day is expected to be 10.26 with a mean absolute deviation of 0.91, mean absolute percentage error of 1.21, and the sum of the absolute errors of 55.53.Please note that although there have been many attempts to predict Kura Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Kura Oncology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Kura Oncology Stock Forecast Pattern
| Backtest Kura Oncology | Kura Oncology Price Prediction | Buy or Sell Advice |
Kura Oncology Forecasted Value
In the context of forecasting Kura Oncology's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Kura Oncology's downside and upside margins for the forecasting period are 5.03 and 15.49, respectively. We have considered Kura Oncology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Kura Oncology stock data series using in forecasting. Note that when a statistical model is used to represent Kura Oncology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.3041 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.9103 |
| MAPE | Mean absolute percentage error | 0.0559 |
| SAE | Sum of the absolute errors | 55.5297 |
Predictive Modules for Kura Oncology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kura Oncology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Kura Oncology
For every potential investor in Kura, whether a beginner or expert, Kura Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kura Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kura. Basic forecasting techniques help filter out the noise by identifying Kura Oncology's price trends.View Kura Oncology Related Equities
| Risk & Return | Correlation |
Kura Oncology Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Kura Oncology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Kura Oncology's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Kura Oncology Market Strength Events
Market strength indicators help investors to evaluate how Kura Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kura Oncology shares will generate the highest return on investment. By undertsting and applying Kura Oncology stock market strength indicators, traders can identify Kura Oncology entry and exit signals to maximize returns.
Kura Oncology Risk Indicators
The analysis of Kura Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kura Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kura stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.39 | |||
| Standard Deviation | 5.17 | |||
| Variance | 26.75 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Kura Oncology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kura Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kura Oncology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kura Oncology Stock:Check out Historical Fundamental Analysis of Kura Oncology to cross-verify your projections. For information on how to trade Kura Stock refer to our How to Trade Kura Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kura Oncology. If investors know Kura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kura Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.35) | Return On Assets (0.29) | Return On Equity (0.46) |
The market value of Kura Oncology is measured differently than its book value, which is the value of Kura that is recorded on the company's balance sheet. Investors also form their own opinion of Kura Oncology's value that differs from its market value or its book value, called intrinsic value, which is Kura Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kura Oncology's market value can be influenced by many factors that don't directly affect Kura Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kura Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kura Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kura Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.